TipRanks

Mark James Litton Insider Profile

4 Followers
Mark James Litton, President & CEO, Director at LeonaBio, holds 59.89K shares in LeonaBio (Ticker: LONA), holds 180.19K shares in Alder Biopharmaceuticals (Ticker: ALDR), holds ― shares in Alpine Immune Sciences (Ticker: ALPN).
tipranks
Mark James Litton

Mark James Litton
LeonaBio (LONA)
President & CEO, Director

Ranked #24,774 out of 109,193 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+10.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$289K
100.00%
A breakdown of Mark James Litton's holdings

Insider Roles

LeonaBio
(LONA)
President & CEO, Director
Roles that Mark James Litton holds in companies

Most Profitable Insider Trade

Stock:
LeonaBio
(LONA)
Rating:Informative Sell
Date:Jan 08, 2024 - Jan 08, 2025
Return:+81.30%
The most profitable trade made by Mark James Litton

Mark James Litton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LeonaBio
Mar 05, 2026
President & CEO, Director
Uninformative Buy
95.24K
$288.69K
ALDR
Alder Biopharmaceuticals
Oct 19, 2016
―
Uninformative Sell
164.98K
$3.40M
ALPN
Alpine Immune Sciences
―
―
―
―
List of latest transactions for each holding click on a transaction to see Mark James Litton's performance on stock

Mark James Litton insider profile FAQ

What is the percentage of profitable transactions made by Mark James Litton?
The percentage of profitable transactions made by Mark James Litton is 67%.
    What is the average return per transaction made by Mark James Litton?
    The average return per transaction made by Mark James Litton is 10.30%.
      What stocks does Mark James Litton hold?
      Mark James Litton holds: LONA, ALDR, ALPN stocks.
        What was Mark James Litton’s latest transaction?
        Mark James Litton latest transaction was an Uninformative Buy of $95.24K.
          What was Mark James Litton's most profitable transaction?
          Mark James Litton’s most profitable transaction was an Informative Sell of LONA stock on January 8, 2024. The return on the trade was 81.30%.
            What is Mark James Litton's role in LeonaBio?
            Mark James Litton's role in LeonaBio is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.